欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
RIPK1-IN-7_2300982-44-7_产品详情
2300982-44-7
  • names:

    RIPK1-IN-7

  • CAS号:

    2300982-44-7

    MDL Number:
  • MF(分子式): C25H22F3N5O2 MW(分子量): 481.47
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
RIPK1-IN-7
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM001765-10mg 10mg 98.27% ¥ 10125.00 ¥ 10125.00 2-3天
- +
¥ 0.00
YZM001765-5mg 5mg 98.27% ¥ 5850.00 ¥ 5850.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 2300982-44-7
Inchi
InchiKey
分子式 Formula C25H22F3N5O2
分子量 Molecular Weight 481.47
溶解度Solubility 生物体外In Vitro:DMSO溶解度62.5 mg/mL(129.81 mM;Need ultrasonic)H2O< 0.1 mg/mL(insoluble)
性状
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
RIPK1-IN-7(CAS:2300982-44-7)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 RIPK1-IN-7 为受体相互作用蛋白激酶 1(RIPK1)抑制剂,Kd值为 4 nM,IC50值为 11 nM
IntroductionRIPK1N is a potent and selectiveRIPK1inhibitor with aKdof 4 nM and an enzymaticIC50of 11 nM. RIPK1N exhibits excellent antimetastasis activity in the experimental B16 melanoma lung metastasis model.
Application1
Application2
Application3
RIPK1-IN-7 为受体相互作用蛋白激酶 1(RIPK1)抑制剂,Kd值为 4 nM,IC50值为 11 nM。RIPK1-IN-7 在 实验性 B16 黑色素瘤肺转移模型中具有良好的抗转移活性。RIPK1-IN-7 is a potent and selectiveRIPK1inhibitor with aKdof 4 nM and an enzymaticIC50of 11 nM. RIPK1-IN-7 exhibits excellent antimetastasis activity in the experimental B16 melanoma lung metastasis model[1].
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Li Y, et al. Identification of 5-(2,3-Dihydro-1 H-indol-5-yl)-7 H-pyrrolo[2,3- d]pyrimidin-4-amine Derivatives as a New Class of Receptor-Interacting Protein Kinase 1 (RIPK1) Inhibitors, Which Showed Potent Activity in a Tumor Metastasis Model. J Med Chem. 2018 Dec 27;61(24):11398-11414.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents